tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ovid Therapeutics Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsOvid Therapeutics Reports Q3 2025 Financial Results
25d ago
Ovid Therapeutics reports Q3 EPS (17c), consensus (15c)
Premium
The Fly
Ovid Therapeutics reports Q3 EPS (17c), consensus (15c)
26d ago
Ovid Therapeutics appoints Alexander as CEO, Levin as Executive Chairman
Premium
The Fly
Ovid Therapeutics appoints Alexander as CEO, Levin as Executive Chairman
26d ago
Morning Movers: Apple shares slip following Jefferies downgrade
PremiumThe FlyMorning Movers: Apple shares slip following Jefferies downgrade
2M ago
Ovid Therapeutics prices private placement up to $175M in gross proceeds
Premium
The Fly
Ovid Therapeutics prices private placement up to $175M in gross proceeds
2M ago
Ovid Therapeutics announces results for Phase 1 study of OV329
Premium
The Fly
Ovid Therapeutics announces results for Phase 1 study of OV329
2M ago
Ovid Therapeutics Navigates FDA Disruptions and Government Challenges
PremiumCompany AnnouncementsOvid Therapeutics Navigates FDA Disruptions and Government Challenges
4M ago
Ovid Therapeutics Reports Increased Revenue Amid Challenges
Premium
Company Announcements
Ovid Therapeutics Reports Increased Revenue Amid Challenges
4M ago
Ovid Therapeutics: Strategic Advances and Promising Developments Justify Buy Rating
Premium
Ratings
Ovid Therapeutics: Strategic Advances and Promising Developments Justify Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100